Letter

Safety of thalidomide

BMJ 1994; 309 doi: 10.1136/bmj.309.6948.193c (Published 16 July 1994)
Cite this as: BMJ 1994;309:193.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. S Asscher
  1. St George's Hospital Medical School, London SW17 0RE.

    EDITOR, - C L Crawford has raised some questions about the prescription of thalidomide on a named patient basis to patients with leprosy in Britain.1 He wrote to me when I was chairman of the Committee on the Safety of Medicines to ask what information a supplier is required by law to provide with thalidomide when supplying the drug to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular